United Services Automobile Association Cytosorbents Corp Transaction History

United Services Automobile Association

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$4.33 - $7.63 $1.42 Million - $2.5 Million	-327,636 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$5.92 - $7.78 $173,160 - $227,565	29,250 Added 9.8%	327,636 $2.17 Million
Q1 2019 May 13, 2019	BUY	$6.82 - $8.56 $112,414 - $141,094	16,483 Added 5.85%	298,386 $2.26 Million
Q4 2018 Feb 13, 2019	BUY	$7.05 - $12.64 $636,615 - $1.14 Million	90,300 Added 47.13%	281,903 $2.28 Million
Q3 2018 Nov 13, 2018	BUY	$10.95 - $14.8 $2.1 Million - $2.84 Million	191,603 New	191,603 $2.47 Million

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.